AQUESTIVE THERAPEUTICS INC (AQST) Institutional Shareholders
AQUESTIVE THERAPEUTICS INC (AQST) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $283.64M in AQST holdings during the latest filing period.
Bratton Capital Management, L.P. is currently the largest disclosed institutional shareholder of AQST tracked by InsiderSet, reporting ownership valued at approximately $40.72M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $36.25M, representing an estimated loss of -10.96% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 64% of the total disclosed AQST value among the investors covered in this analysis. Major shareholders include Bratton Capital Management, L.P., Blackrock, Inc., Rtw Investments, Lp, and several other long-term asset managers with concentrated positions in AQUESTIVE THERAPEUTICS INC (AQST).
This page ranks the largest institutional AQST shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
167
Total Reported Value
$283.64M
Largest Holder
Bratton Capital Management, L.P.
Largest Position
$40.72M
Insider Transactions (90d)
5
Latest Filing Quarter
Q2 2026
New Institutional Positions
180
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Bratton Capital Management, L.P. | 100.00% | 9,810,958 | $40,715,476 | $36,251,490 | -$4,463,986 | -10.96% | |
| Blackrock, Inc. | 0.00% | 7,509,071 | $31,162,644 | $27,746,017 | -$3,416,627 | -10.96% | |
| Rtw Investments, Lp | 0.31% | 7,426,471 | $30,819,855 | $27,440,810 | -$3,379,045 | -10.96% | |
| Arete Wealth Advisors, Llc | 1.05% | 121,485 | $14,115,949 | $448,887 | -$13,667,062 | -96.82% | |
| Federated Hermes, Inc. | 0.02% | 2,940,339 | $12,202,407 | $10,864,553 | -$1,337,854 | -10.96% | |
| Balyasny Asset Management L.P. | 0.02% | 2,900,570 | $12,037,366 | $10,717,606 | -$1,319,760 | -10.96% | |
| State Street Corp | 0.00% | 2,546,191 | $10,566,693 | $9,408,176 | -$1,158,517 | -10.96% | |
| Samsara Biocapital, Llc | 1.01% | 2,500,000 | $10,375,000 | $9,237,500 | -$1,137,500 | -10.96% | |
| Geode Capital Management, Llc | 0.00% | 2,408,191 | $9,996,351 | $8,898,266 | -$1,098,085 | -10.98% | |
| Bank Of America Corp | 0.00% | 2,405,050 | $9,980,958 | $8,886,660 | -$1,094,298 | -10.96% | |
| Sio Capital Management, Llc | 1.15% | 1,922,887 | $7,979,981 | $7,105,067 | -$874,914 | -10.96% | |
| Morgan Stanley | 0.00% | 1,591,792 | $6,605,938 | $5,881,671 | -$724,267 | -10.96% | |
| Wasatch Advisors Lp | 0.04% | 1,385,843 | $5,765,107 | $5,120,690 | -$644,417 | -11.18% | |
| Blue Owl Capital Holdings Lp | 1.50% | 1,347,932 | $5,593,918 | $4,980,609 | -$613,309 | -10.96% | |
| Two Sigma Investments, Lp | 0.00% | 1,139,404 | $4,728,527 | $4,210,098 | -$518,429 | -10.96% | |
| Commonwealth Equity Services, Llc | 0.01% | 1,046,175 | $4,352,090 | $3,865,617 | -$486,473 | -11.18% | |
| Wells Fargo & Company/Mn | 0.00% | 1,034,644 | $4,293,773 | $3,823,010 | -$470,763 | -10.96% | |
| Jane Street Group, Llc | 0.00% | 1,030,050 | $4,274,707 | $3,806,035 | -$468,672 | -10.96% | |
| Bnp Paribas Financial Markets | 0.00% | 809,007 | $3,357,379 | $2,989,281 | -$368,098 | -10.96% | |
| Barclays Plc | 0.00% | 799,163 | $3,316,526 | $2,952,907 | -$363,619 | -10.96% | |
| Northern Trust Corp | 0.00% | 732,504 | $3,039,892 | $2,706,602 | -$333,290 | -10.96% | |
| Propel Bio Management, Llc | 1.86% | 710,988 | $2,950,600 | $2,627,101 | -$323,499 | -10.96% | |
| Everstar Asset Management, Llc | 1.23% | 611,943 | $2,545,683 | $2,261,129 | -$284,554 | -11.18% | |
| Citadel Advisors Llc | 0.00% | 565,203 | $2,345,592 | $2,088,425 | -$257,167 | -10.96% | |
| Goldman Sachs Group Inc | 0.00% | 466,767 | $1,937,083 | $1,724,704 | -$212,379 | -10.96% | |
| Ubs Group Ag | 0.00% | 464,207 | $1,926,459 | $1,715,245 | -$211,214 | -10.96% | |
| Bracebridge Capital, Llc | 0.34% | 459,216 | $1,905,746 | $1,696,803 | -$208,943 | -10.96% | |
| Dafna Capital Management Llc | 0.35% | 368,415 | $1,528,922 | $1,361,293 | -$167,629 | -10.96% | |
| Stifel Financial Corp | 0.00% | 359,903 | $1,493,596 | $1,329,842 | -$163,754 | -10.96% | |
| Susquehanna International Group, Llp | 0.00% | 337,635 | $1,401,185 | $1,247,561 | -$153,624 | -10.96% | |
| Diametric Capital, Lp | 0.36% | 335,443 | $1,392,088 | $1,239,462 | -$152,626 | -10.96% | |
| Wellington Management Group Llp | 0.00% | 290,060 | $1,203,749 | $1,071,772 | -$131,977 | -10.96% | |
| Point72 Asset Management, L.P. | 0.00% | 283,734 | $1,177,496 | $1,048,397 | -$129,099 | -10.96% | |
| Walleye Capital Llc | 0.01% | 282,568 | $1,175,483 | $1,044,089 | -$131,394 | -11.18% | |
| Simplify Asset Management Inc. | 0.02% | 278,723 | $1,159,488 | $1,029,881 | -$129,607 | -11.18% | |
| State Of Wisconsin Investment Board | 0.00% | 279,287 | $1,159,041 | $1,031,965 | -$127,076 | -10.96% | |
| Awm Investment Company, Inc. | 0.12% | 270,400 | $1,122,160 | $999,128 | -$123,032 | -10.96% | |
| Charles Schwab Investment Management Inc | 0.00% | 267,419 | $1,109,789 | $988,113 | -$121,676 | -10.96% | |
| Bank Of New York Mellon Corp | 0.00% | 255,184 | $1,059,015 | $942,905 | -$116,110 | -10.96% | |
| Nuveen, Llc | 0.00% | 253,465 | $1,051,880 | $936,553 | -$115,327 | -10.96% | |
| Rosalind Advisors, Inc. | 0.43% | 250,000 | $1,037,500 | $923,750 | -$113,750 | -10.96% | |
| Squarepoint Ops Llc | 0.00% | 249,482 | $1,035,350 | $921,836 | -$113,514 | -10.96% | |
| Latash Investments, Llc | 0.78% | 243,134 | $1,009,006 | $898,380 | -$110,626 | -10.96% | |
| Hudson Bay Capital Management Lp | 0.01% | 234,000 | $971,100 | $864,630 | -$106,470 | -10.96% | |
| Russell Investments Group, Ltd. | 0.00% | 226,163 | $938,577 | $835,672 | -$102,905 | -10.96% | |
| Creative Planning | 0.00% | 183,188 | $760,230 | $676,880 | -$83,350 | -10.96% | |
| Alliancebernstein L.P. | 0.00% | 91,990 | $594,255 | $339,903 | -$254,352 | -42.80% | |
| Aquatic Capital Management Llc | 0.02% | 141,350 | $586,602 | $522,288 | -$64,314 | -10.96% | |
| Rhumbline Advisers | 0.00% | 136,539 | $566,626 | $504,512 | -$62,114 | -10.96% | |
| Bleakley Financial Group, Llc | 0.01% | 135,767 | $563,433 | $501,659 | -$61,774 | -10.96% |
Frequently asked questions about AQST
Who owns the most AQST stock?
The largest holders of AQST are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for AQUESTIVE THERAPEUTICS INC (AQST).
Is AQST widely held by superinvestors?
Many widely followed stocks like AQST appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly AQST is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.